Please assess the completion status of the following clinical trial:

Trial Title: Study to Assess the Effect of Ticagrelor on Coronary Blood Flow in Healthy Male Subjects.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Suitable for ECG recording of CBFV and have no adverse reaction to adenosine challenge~* Have a body mass index between 18 and 30 kg/m2~Exclusion Criteria:~* History of clinically significant disease or disorder.~* Abnormal vital signs

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): Adenosinladder; Ticagrelor (180 mg), Adenosinladder ; Theophylline (5 mg/kg), Adenosinladder
- 2 (Type: PLACEBO_COMPARATOR): Adenosinladder; Placebo, Adenosinladder; Theophylline (5 mg/kg), Adenosinladder

Based on this trial design, predict the completion outcome and termination type (if applicable).